Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial-Reference-Cited by-同舟云学术

Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial

Published:2023-07 Issue:7 Volume:11 Page:454-464
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Atila Cihan,Holze Friederike,Murugesu Rakithan,Rommers Nikki,Hutter Nina,Varghese Nimmy,Sailer Clara O,Eckert Anne,Heinrichs Markus,Liechti Matthias E,Christ-Crain Mirjam

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference35 articles.

1. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine;Meyer-Lindenberg;Nat Rev Neurosci,2011

2. Diabetes insipidus;Christ-Crain;Nat Rev Dis Primers,2019

3. Low plasma oxytocin levels and increased psychopathology in hypopituitary men with diabetes insipidus;Aulinas;J Clin Endocrinol Metab,2019

4. Oxytocin alterations and neurocognitive domains in patients with hypopituitarism;Eisenberg;Pituitary,2019

5. De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function;Gebert;Psychoneuroendocrinology,2018

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants;Neuropsychopharmacology;2024-08-23

2. Understanding oxytocin in human physiology and pathophysiology: A path towards therapeutics;Comprehensive Psychoneuroendocrinology;2024-08

3. The oxytocin system in patients with craniopharyngioma: A systematic review;2024-08-01

4. Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”;Journal of Psychopharmacology;2024-07-28

5. Approach to the Patient: New Era Emerges for Craniopharyngioma Management;The Journal of Clinical Endocrinology & Metabolism;2024-07-23